Literature DB >> 1418222

Ganglioside distribution in murine neural tumors.

T N Seyfried1, M el-Abbadi, M L Roy.   

Abstract

The ganglioside composition of seven experimental brain tumors was examined in C57BL/6J mice. The tumors were produced from 20-methylcholanthrene (20-MC) implantation into either the cerebrum or cerebellum and were maintained in serial transplants through many generations. The tumors studied were grown subcutaneously as solid tumors, and cells from two of the tumors were also studied in culture. Histologically, all of the tumors were similar and could be broadly classified as highly malignant, poorly differentiated anaplastic astrocytomas. The total ganglioside sialic acid content of the solid tumors was markedly lower than that in adult mouse brain. In addition to N-acetylneuraminic acid (NeuAc), the gangliosides in the solid tumors contained significant amounts of N-glycolylneuraminic acid (NeuGc). The seven solid tumors fell into two general groups with respect to ganglioside composition. Furthermore, the differences in ganglioside composition between the two tumor groups were strongly associated with differences in tumor cell cohesion. The tumors in one group had high levels of GM3 hematosides, low levels of oligosialogangliosides, and grew as firm cohesive tissues. The tumors in the other group, however, had lower levels of GM3 hematosides, noticeable amounts of oligosialogangliosides and grew as soft noncohesive tissues. In culture, clonal cells from one of the tumors in the first group grew as clumps or islands and contained GM3 as the only major ganglioside, whereas clonal cells from a tumor in the second group grew as sheets or monolayers and contained little GM3, but expressed several gangliosides with complex structures. In marked contrast to the gangliosides in the solid tumors, the gangliosides in the cultured tumor cells contained trace amounts of NeuGc. Since NeuGc containing gangliosides are abundant in mouse nonneural tissues, the high content of NeuGc gangliosides in the solid tumors may arise from infiltration of nonneural tissue elements, e.g., macrophages, lymphocytes, and endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1418222     DOI: 10.1007/bf03159989

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  35 in total

1.  Medium dose intermittent cyclophosphamide induces immunogenic cell death and cancer cell autonomous type I interferon production in glioma models.

Authors:  Bin Du; David J Waxman
Journal:  Cancer Lett       Date:  2019-11-22       Impact factor: 8.679

2.  Plasmonic gold nanostar-mediated photothermal immunotherapy for brain tumor ablation and immunologic memory.

Authors:  Yang Liu; Pakawat Chongsathidkiet; Bridget M Crawford; Ren Odion; Cosette A Dechant; Hanna R Kemeny; Xiuyu Cui; Paolo F Maccarini; Christopher D Lascola; Peter E Fecci; Tuan Vo-Dinh
Journal:  Immunotherapy       Date:  2019-09-18       Impact factor: 4.196

3.  Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach.

Authors:  Nicholas T Seyfried; Leanne C Huysentruyt; James A Atwood; Qiangwei Xia; Thomas N Seyfried; Ron Orlando
Journal:  Cancer Lett       Date:  2008-02-20       Impact factor: 8.679

4.  Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer.

Authors:  Thomas N Seyfried; Purna Mukherjee
Journal:  J Oncol       Date:  2010-06-20       Impact factor: 4.375

Review 5.  Why Is N-Glycolylneuraminic Acid Rare in the Vertebrate Brain?

Authors:  Leela R L Davies; Ajit Varki
Journal:  Top Curr Chem       Date:  2015

6.  Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer.

Authors:  Michael A Kiebish; Xianlin Han; Hua Cheng; Jeffrey H Chuang; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2008-08-13       Impact factor: 5.922

Review 7.  A role for the NG2 proteoglycan in glioma progression.

Authors:  William B Stallcup; Feng-Ju Huang
Journal:  Cell Adh Migr       Date:  2008-07-13       Impact factor: 3.405

8.  A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion.

Authors:  Laura M Shelton; Purna Mukherjee; Leanne C Huysentruyt; Ivan Urits; Joshua A Rosenberg; Thomas N Seyfried
Journal:  J Neurooncol       Date:  2010-01-13       Impact factor: 4.130

9.  Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model.

Authors:  P Mukherjee; M M El-Abbadi; J L Kasperzyk; M K Ranes; T N Seyfried
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

10.  In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours.

Authors:  Michael A Kiebish; Xianlin Han; Hua Cheng; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2009-05-27       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.